Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7618631 Treatment with anti-ErbB2 antibodies and EGFR-targeted drugs

Patent 7618631 was granted and assigned to Genentech on November, 2009 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 30 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 30 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12128103 Adjuvant treatment of HER2-positive breast cancer
0
Edits on 9 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 9 Oct, 2024
Edits on 29 May, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 29 May, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11992529 Adjuvant treatment of HER2-positive breast cancer
0
Edits on 16 Sep, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 16 Sep, 2023
Edits made to:
Article (+170 characters)
Article

Patent abstract

The present application describes methods for treating cancer with anti-ErbB2 antibodies, such as humanized anti-ErbB2 antibodies, and EGFR-targeted drugs.

Edits on 25 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 25 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 07618631 Treatment with anti-ErbB2 antibodies and EGFR-targeted drugs US Patent 7618631 Treatment with anti-ErbB2 antibodies and EGFR-targeted drugs

Infobox
Patent Number
0761863100
Patent Number
761863100
Edits on 24 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 24 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=0761863100
Edits on 3 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 3 Apr, 2023
Infobox
Is a
Patent
Patent
0
Current Assignee
Genentech
Genentech
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
076186310
Date of Patent
November 17, 2009
0
Patent Application Number
111544650
Date Filed
June 16, 2005
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=076186310
Patent Primary Examiner
‌
Alana M. Harris
0
Edits on 23 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 23 Sep, 2022
Infobox
Is a
Patent
Patent
0
Current Assignee
Genentech
Genentech
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
076186310
Date of Patent
November 17, 2009
0
Patent Application Number
111544650
Date Filed
June 16, 2005
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=076186310
Patent Primary Examiner
‌
Alana M. Harris
0
Edits on 18 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 18 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=07618631
Edits on 3 Dec, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 3 Dec, 2021
Edits made to:
Infobox (+8 properties)
‌

 US Patent 07618631 Treatment with anti-ErbB2 antibodies and EGFR-targeted drugs

Infobox
Is a
Patent
Patent
Current assignee
Genentech
Genentech
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
07618631
Date of patent
November 17, 2009
Patent application number
11154465
Date Filed
June 16, 2005
Patent primary examiner
‌
Alana M. Harris

Find more entities like US Patent 7618631 Treatment with anti-ErbB2 antibodies and EGFR-targeted drugs

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo